Catalyst Event
Shanghai Junshi Biosciences Co Ltd (1877) · Other
From Akros SCHK HK-Global Genomics Index (ASHGGENM)
4/26/2026, 12:00:00 AM
Presented positive preliminary clinical results for multiple pipeline candidates at the 2026 AACR Annual Meeting, including the PD-1/VEGF bispecific antibody JS207 for liver and colorectal cancer, and the EGFR/HER3 bispecific ADC JS212 for solid tumors.
Korean Translation
2026년 미국암연구학회(AACR) 연례회의에서 다수의 파이프라인 후보물질에 대한 긍정적인 초기 임상 결과를 발표함. 간암 및 대장암 치료를 위한 PD-1/VEGF 이중항체 JS207과 고형암 치료를 위한 EGFR/HER3 이중항체 ADC JS212 등이 포함됨.
Related Recent Events
WuXi Biologics (Cayman) Inc (2269) · Other
The U.S. Office of Management and Budget (OMB) is scheduled to publish a full list of 'biotechnology companies of concern' (BCCs) by December 18, 2026, under the BIOSECURE Act; High importance is justified by the potential for severe regulatory risk causing a >10% price impact scheduled.
12/18/2026, 12:00:00 AM
Livzon Pharmaceutical Group Inc (1513) · Other
Ex-dividend date on June 16, 2026, for the 2025 final cash dividend of RMB 14.3 per 10 shares, with payment on July 13, 2026, scheduled. This consistent dividend payout is estimated to have a minor positive impact on investor sentiment.
6/16/2026, 12:00:00 AM
Grand Pharmaceutical Group Ltd (512) · Other
Ex-dividend date for a proposed final dividend of HK$0.169 per share for the year ended December 31, 2025, on 2026-06-12 scheduled. Low importance as dividend ex-dates typically result in minor price adjustments.
6/12/2026, 12:00:00 AM
Hangzhou Tigermed Consulting Co Ltd (3347) · Other
Annual General Meeting scheduled for June 2, 2026, to vote on the 2025 profit distribution plan, a final dividend of RMB 1.26 per 10 shares, and a general mandate for the board to repurchase H-shares. Routine AGM and dividend announcement are likely to cause a price impact of 1% or more, scheduled.
6/2/2026, 12:00:00 AM
GRAIL Inc (GRAL) · Other
GRAIL to present additional data from the NHS-Galleri trial at the 2026 ASCO Annual Meeting on May 30, 2026, scheduled. High importance estimated as clinical data is a key valuation driver.
5/30/2026, 12:00:00 AM
ANTA Sports Products Limited (2020) · Other
Ex-dividend date for the final FY2025 dividend of HK$1.08 per share is scheduled for May 15, 2026.
5/15/2026, 12:00:00 AM